Financial disclosure and toxic products: encouraging wall street to anticipate product risk and exercise precaution.

Sanford Lewis, Margaret M Byrne

Research output: Contribution to journalArticle

Abstract

Amidst discussion by policymakers about how regulators' failure to ensure disclosure of risks contributed to the current financial crisis, we assess how emerging product toxicity risks are addressed in companies' financial reports. Will corporations blindside investors with "the next asbestos?" Existing disclosures are found lacking in the specificity needed to forewarn of liabilities and reputational damage from the use of potentially harmful materials-from nanotechnologies, to asthmagens, to perfluorinated compounds. Improved standards could protect investors while also enhancing corporate incentives to use safer materials. Reforms by the Securities and Exchange Commission and the Financial Accounting Standards Board are recommended.

Original languageEnglish
Pages (from-to)31-58
Number of pages28
JournalNew solutions : a journal of environmental and occupational health policy : NS
Volume19
Issue number1
DOIs
StatePublished - Aug 13 2009
Externally publishedYes

Fingerprint

Poisons
Disclosure
Nanotechnology
Asbestos
Motivation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Financial disclosure and toxic products : encouraging wall street to anticipate product risk and exercise precaution. / Lewis, Sanford; Byrne, Margaret M.

In: New solutions : a journal of environmental and occupational health policy : NS, Vol. 19, No. 1, 13.08.2009, p. 31-58.

Research output: Contribution to journalArticle

@article{1b7a30d021294066af003035440ed6fa,
title = "Financial disclosure and toxic products: encouraging wall street to anticipate product risk and exercise precaution.",
abstract = "Amidst discussion by policymakers about how regulators' failure to ensure disclosure of risks contributed to the current financial crisis, we assess how emerging product toxicity risks are addressed in companies' financial reports. Will corporations blindside investors with {"}the next asbestos?{"} Existing disclosures are found lacking in the specificity needed to forewarn of liabilities and reputational damage from the use of potentially harmful materials-from nanotechnologies, to asthmagens, to perfluorinated compounds. Improved standards could protect investors while also enhancing corporate incentives to use safer materials. Reforms by the Securities and Exchange Commission and the Financial Accounting Standards Board are recommended.",
author = "Sanford Lewis and Byrne, {Margaret M}",
year = "2009",
month = "8",
day = "13",
doi = "10.2190/NS.19.1.d",
language = "English",
volume = "19",
pages = "31--58",
journal = "New Solutions",
issn = "1048-2911",
publisher = "Baywood Publishing Co. Inc.",
number = "1",

}

TY - JOUR

T1 - Financial disclosure and toxic products

T2 - encouraging wall street to anticipate product risk and exercise precaution.

AU - Lewis, Sanford

AU - Byrne, Margaret M

PY - 2009/8/13

Y1 - 2009/8/13

N2 - Amidst discussion by policymakers about how regulators' failure to ensure disclosure of risks contributed to the current financial crisis, we assess how emerging product toxicity risks are addressed in companies' financial reports. Will corporations blindside investors with "the next asbestos?" Existing disclosures are found lacking in the specificity needed to forewarn of liabilities and reputational damage from the use of potentially harmful materials-from nanotechnologies, to asthmagens, to perfluorinated compounds. Improved standards could protect investors while also enhancing corporate incentives to use safer materials. Reforms by the Securities and Exchange Commission and the Financial Accounting Standards Board are recommended.

AB - Amidst discussion by policymakers about how regulators' failure to ensure disclosure of risks contributed to the current financial crisis, we assess how emerging product toxicity risks are addressed in companies' financial reports. Will corporations blindside investors with "the next asbestos?" Existing disclosures are found lacking in the specificity needed to forewarn of liabilities and reputational damage from the use of potentially harmful materials-from nanotechnologies, to asthmagens, to perfluorinated compounds. Improved standards could protect investors while also enhancing corporate incentives to use safer materials. Reforms by the Securities and Exchange Commission and the Financial Accounting Standards Board are recommended.

UR - http://www.scopus.com/inward/record.url?scp=68349109823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349109823&partnerID=8YFLogxK

U2 - 10.2190/NS.19.1.d

DO - 10.2190/NS.19.1.d

M3 - Article

C2 - 19447757

AN - SCOPUS:68349109823

VL - 19

SP - 31

EP - 58

JO - New Solutions

JF - New Solutions

SN - 1048-2911

IS - 1

ER -